You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

IRF2BPL

Showing 1 - 25 of 231
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Autism Spectrum Disorder, Movement Disorders, Seizures Trial in Cincinnati (No interventions are planned)

Recruiting
  • Autism Spectrum Disorder
  • +4 more
  • No interventions are planned
  • Cincinnati, Ohio
    Cincinnati Children's Hospital Medical Center
Jul 27, 2021

People Who Have Genetic Changes and Features of Autism: Simons

Recruiting
  • 16P11.2 Deletion Syndrome
  • +184 more
    • New York, New York
    • +1 more
    Jan 6, 2023

    Treatment Resistant Depression Trial in London (BPL-003)

    Not yet recruiting
    • Treatment Resistant Depression
    • London, United Kingdom
    • +1 more
    Dec 13, 2022

    Hypertension, Type 2 Diabetes, Metabolic Syndrome Trial in Tbilisi (iRF System Multi-organ Denervation, Control Procedure)

    Recruiting
    • Hypertension
    • +2 more
    • iRF System Multi-organ Denervation
    • Control Procedure
    • Tbilisi, Georgia
    • +1 more
    Jun 16, 2022

    Alcohol Use Disorder Trial in London (BPL-003)

    Not yet recruiting
    • Alcohol Use Disorder
    • London, United Kingdom
      King's College London
    Dec 21, 2022

    Diabetes, Type 2 Trial in United States (iRF System Hepatic Denervation)

    Active, not recruiting
    • Diabetes Mellitus, Type 2
    • iRF System Hepatic Denervation
    • Birmingham, Alabama
    • +7 more
    Aug 10, 2022

    Short Lasting Unilateral Neuralgiform Headache Attacks Trial in London (Psilocybin)

    Recruiting
    • Short Lasting Unilateral Neuralgiform Headache Attacks
    • London, United Kingdom
      King's College London
    Apr 1, 2022

    Obesity, Morbid, Diabetes, Type 2, Hypertension Trial in Basel (Long BPL LRYGB, Short BPL LRYGB)

    Recruiting
    • Obesity, Morbid
    • +4 more
    • Long BPL LRYGB
    • Short BPL LRYGB
    • Basel, Switzerland
      Clarunis University Center for Gastrointestinal and Liver Diseas
    Aug 11, 2020

    Diabetes, Type 2 Trial in Madrid (BPL-1 Probiotic capsules, Placebo)

    Completed
    • Diabetes Mellitus, Type 2
    • BPL-1 Probiotic capsules
    • Placebo
    • Madrid, Spain
      Hospital Universitario de La princesa
    Jul 6, 2020

    ALK-Positive Large B-Cell Lymphoma, Burkitt-Like Lymphoma With 11q Aberration, DLBCL Activated B-Cell Type Trial in United

    Active, not recruiting
    • ALK-Positive Large B-Cell Lymphoma
    • +34 more
    • Phoenix, Arizona
    • +32 more
    Jan 3, 2023

    Obesity, Diabetes, Type 2 Trial in Santa Maria Da Feira (Short BPL RYGB, Long BPL RYGB)

    Unknown status
    • Obesity
    • Diabetes Mellitus, Type 2
    • Short BPL RYGB
    • Long BPL RYGB
    • Santa Maria Da Feira, Aveiro, Portugal
      São Sebastião Hospital
    Dec 10, 2019

    Treatment Resistant Depression Trial in New York (BPL-003)

    Not yet recruiting
    • Treatment Resistant Depression
    • New York, New York
      New York State Psychiatric Institute
    May 12, 2023

    Influenza Trial run by the NIAID (BPL-1357, IM Placebo, IN Placebo)

    Recruiting
    • Influenza
    • BPL-1357
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Aug 4, 2022

    Lymphoma Trial in China (Brentuximab Vedotin, Cyclophosphamide, Doxorubicin)

    Not yet recruiting
    • Lymphoma
    • Brentuximab Vedotin
    • +3 more
    • Beijing, China
    • +15 more
    Jan 4, 2023

    Early Real-world Evidence of Brolucizumab in Neovascular

    Completed
    • Neurovascular Age-related Macular Degeneration
      • Bangalore, India
      • +3 more
      Apr 26, 2023

      Unresectable Angiosarcoma Trial in Tokyo (BNCT)

      Recruiting
      • Unresectable Angiosarcoma
      • BNCT
      • Tokyo, Japan
        National Cancer Center Hospital
      Nov 21, 2022

      Ranibizumab 0.5 mg for Diabetic Macular Edema With Initial

      Completed
      • Diabetic Macular Edema
        • Seoul, Korea, Republic of
          Novartis Investigative Site
        Apr 4, 2023

        Pharmacokinetics in Healthy Adults Trial in London (BPL-003, Placebo)

        Recruiting
        • Pharmacokinetics in Healthy Adults
        • London, United Kingdom
          Hammersmith Medicines Research
        Apr 21, 2022

        Renal Cell Carcinoma Trial in Worldwide (Atezolizumab, Placebo)

        Completed
        • Renal Cell Carcinoma
        • Scottsdale, Arizona
        • +185 more
        Jan 30, 2023

        rOutine Using afLibERcept: Strict vs relAxed retreatmeNT Regimen

        Completed
        • Age Related Macular Degeneration
        • Bern, Switzerland
        • +1 more
        Nov 28, 2022

        Brolucizumab in Pre-treated nAMD in the Real-world Setting

        Not yet recruiting
        • Neovascular Age-related Macular Degeneration
        • Brolucizumab
        • (no location specified)
        Aug 8, 2022

        NSCLC Trial in China (Atezolizumab, Pemetrexed, Carboplatin)

        Recruiting
        • Non-Small Cell Lung Cancer
        • Beijing City, China
        • +20 more
        Aug 5, 2022

        Outcomes of Tolerating Subretinal Fluid in Type 1 MNV and PCV

        Recruiting
        • Polypoidal Choroidal Vasculopathy
        • +2 more
        • Intravitreal aflibercept injection
        • Seoul, Korea, Republic of
          Jae Hui Kim
        Dec 20, 2022

        Stroke Rehabilitation, Functional Recovery, and

        Recruiting
        • Stroke
          • Salt Lake City, Utah
            University of Utah
          May 29, 2022

          Carcinoma, Renal Cell Trial in Worldwide (Atezolizumab, Cabozantinib)

          Active, not recruiting
          • Carcinoma, Renal Cell
          • Tucson, Arizona
          • +147 more
          Jan 24, 2023